AIH5 Re13-Re14

Reassortant Newcastle Disease & H9 Avian Influenza Vaccine, Inactivated

Reassortant Avian Influenza Virus H5 Bivalent Vaccine, Inactivated (Strains H5-Re13 + H5-Re14), against H5 clades 2.3.4.4h and 2.3.4.4b. Delivered via intramuscular or subcutaneous injection, the vaccine offers 6 months of immunity for chickens and 4 months for ducks and geese with a booster.

  • Vaccine Type: Inactivated Viral Vaccine
  • Target Species: Chickens
  • Indication / Application: Prevention of Newcastle disease and H9 avian influenza
  • Immunity Onset: 14 days post-vaccination
  • Immunity Duration: 6 months
  • Manufacturing: GMP-certified
  • Supply Mode: Bulk, distributor, OEM
  • Origin: China

AI H5 Inactivated Vaccine Description

This inactivated bivalent avian influenza vaccine is formulated with two reassortant H5 subtype strains:

  • H5-Re13 (H5N6) – targeting clade 2.3.4.4h
  • H5-Re14 (H5N8) – targeting clade 2.3.4.4b

These strains are selected to provide broad cross-protection against currently circulating H5 avian influenza variants, which are responsible for significant outbreaks in poultry worldwide.

Avian influenza (AI) is a highly contagious viral disease causing severe respiratory distress, decreased egg production, high mortality, and major economic losses. Effective vaccination is critical for disease control, especially in endemic and high-risk regions.

This oil-emulsion inactivated vaccine induces strong and long-lasting humoral immunity, with protection developing 14 days post-vaccination.

  • Chickens: Protection lasts up to 6 months
  • Ducks & Geese: Require booster vaccination after 3 weeks, with protection lasting 4 months

The vaccine is suitable for commercial poultry farms, breeder operations, and integrated production systems, particularly where H5 subtype variants are prevalent.

Immunization Program

  • Chickens:
    • Single vaccination
    • Immunity duration: ~6 months
  • Ducks & Geese:
    • Primary vaccination
    • Booster after 3 weeks
    • Immunity duration: ~4 months

Dosage & Administration

  • Route:
    • Intramuscular (chest)
    • Subcutaneous (neck)

Dosage:

  • Chickens:
    • 2–5 weeks: 0.3 mL
    • 5 weeks: 0.5 mL
  • Ducks & Geese:
    • 2–5 weeks: 0.5 mL
    • 5 weeks: 1.0 mL

Composition

  • Inactivated H5N6 (H5-Re13): HA titer ≥ 1:256 (pre-inactivation)
  • Inactivated H5N8 (H5-Re14): HA titer ≥ 1:256 (pre-inactivation)

Product Characteristics

  • Appearance: Milky white uniform emulsion
  • Stable oil-adjuvanted formulation
  • Strong immune response induction

Safety & Adverse Reactions

  • No significant adverse reactions observed
  • Safe for use in healthy poultry

Precautions

  • Do NOT use in:
    • Poultry infected with avian influenza
    • Birds in poor health condition
  • Do not freeze
  • Inspect before use:
    • Do not use if damaged, contaminated, or demulsified
  • Before use:
    • Bring to room temperature
    • Shake thoroughly
  • Use aseptic techniques:
    • Replace needles regularly (preferably one needle per bird)
  • After opening:
    • Use within the same day
  • Withdrawal period:
    • Do not use within 28 days before slaughter
  • Dispose of vaccine materials safely

Packaging & Specification

  • Specification: 500 mL/bottle
  • Packaging: 20 bottles/carton

Storage & Shelf Life

  • Storage: 2–8°C
  • Do NOT freeze
  • Shelf Life: 24 months

Contact us today to become a partner!

Inquire Now

Relate News

Get a free quote

Tell us what you need and we will get back to you within eight hours!

CONTACT US

Become our partner